We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00137826
First Posted: August 30, 2005
Last Update Posted: December 26, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Massachusetts General Hospital
University of Chicago
Information provided by (Responsible Party):
Pasi A. Janne, MD, PhD, Dana-Farber Cancer Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)